跳至主要内容
临床试验/JPRN-UMIN000006350
JPRN-UMIN000006350已完成未知

Preventive effect of aliskiren on migraine complicated with hypertension. - Anti-migraine effect of aliskiren

Department of Neurology, School of Medicine, Keio University0 个研究点目标入组 20 人开始时间: 2011年9月16日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Individuals taking an ACE inhibitor or ARB. 2. Those who fail to submit informed consent. 3. Those who may be allergic to aliskiren or candesartan. 4. SBP>180 mmHg or DBP>110 mmHg. 5. Those who are pregnant or hope to get pregnant. 6. Menstruation-related migraine patients. 7. Those who are taking cyclosporine. 8. Those who have severe hepatic dysfunction and/or renal dysfunction. 9. Those who are judged not to be eligible for entry to this study by their attending physician.

研究者

发起方
Department of Neurology, School of Medicine, Keio University

相似试验